15571 studies found for:    Open Studies | "Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Natural Killer Cells and Bortezomib to Treat Cancer
Conditions: Lung or Prostatic Neoplasms;   Colorectal or Kidney Neoplasms;   Pancreatic Neoplasms;   Leukemia, Myelogenous, Chronic Lymphocytic Leukemia, BCR-ABL Positive;   Melanoma;   CLL
Intervention: Drug: NK cells +CliniMACs CD3 and CD56 systems
22 Not yet recruiting Pembrolizumab in Treating Patients With HIV and Relapsed, Refractory, or Disseminated Malignant Neoplasms
Conditions: AIDS-Related Non-Hodgkin Lymphoma;   Classical Hodgkin Lymphoma;   HIV Infection;   Kaposi Sarcoma;   Locally Advanced Malignant Neoplasm;   Metastatic Malignant Neoplasm;   Recurrent Hepatocellular Carcinoma;   Recurrent Hodgkin Lymphoma;   Recurrent Kaposi Sarcoma;   Recurrent Malignant Neoplasm;   Recurrent Melanoma;   Recurrent Melanoma of the Skin;   Recurrent Non-Hodgkin Lymphoma;   Recurrent Non-Small Cell Lung Carcinoma;   Refractory Hodgkin Lymphoma;   Refractory Malignant Neoplasm;   Solid Neoplasm;   Stage IIIA Hepatocellular Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIA Skin Melanoma;   Stage IIIB Hepatocellular Carcinoma;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IIIB Skin Melanoma;   Stage IIIC Hepatocellular Carcinoma;   Stage IIIC Skin Melanoma;   Stage IV Non-Small Cell Lung Cancer;   Stage IV Skin Melanoma;   Stage IVA Hepatocellular Carcinoma;   Stage IVB Hepatocellular Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab
23 Recruiting Efficacy of a Smart Management Strategy for Health (SMASH) Program for Overcoming Cancer Crisis and Growing Positively
Conditions: Breast Neoplasms;   Lung Neoplasms;   Colorectal Neoplasms;   Stomach Neoplasms
Interventions: Behavioral: Online health management program;   Behavioral: Health coaching;   Behavioral: Workshop;   Behavioral: Standard health educational booklet
24 Recruiting Open-Label, Dose-Escalation Study of INCB054828 in Subjects With Advanced Malignancies
Conditions: Malignant Solid Tumour;   Carcinoma, Non-Small-Cell Lung;   Stomach Neoplasms;   Urothelial Carcinoma;   Endometrial Neoplasms;   Multiple Myeloma;   MPN
Intervention: Drug: INCB054828
25 Recruiting Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVR
Conditions: Prostatic Neoplasms;   Breast Neoplasms;   Colorectal Neoplasms;   Melanoma;   Leukemia
Intervention: Behavioral: Interactive Voice Response (IVR) Reminders
26 Recruiting DOvEEgene: Developing and Validating a Novel Molecular Screening Test for the Early Diagnosis of Cancer of the Endometrium, Tubes and Ovaries
Conditions: Ovarian Neoplasms;   Endometrial Neoplasms;   Endometrial Cancer;   Ovarian Cancer;   Screening;   Safety;   Reduced Mortality;   Reduced Morbidity;   Early Diagnosis
Intervention:
27 Recruiting Tumor Bank for Blood Samples
Conditions: Ovarian Neoplasms;   Breast Neoplasms;   Colorectal Neoplasms;   Neoplasms of the Female Genitalia;   Lung Neoplasms;   Endocrine Gland Neoplasms
Intervention: Other: Blood collection
28 Recruiting Tumor Bank for Tissue Samples
Conditions: Ovarian Neoplasms;   Breast Neoplasms;   Colorectal Neoplasms;   Neoplasms of the Female Genitalia;   Lung Neoplasms;   Endocrine Gland Neoplasms
Interventions: Other: Tumor tissue collection;   Other: Sampling of ascites and pleural effusion;   Other: Collecting urine samples;   Other: Collecting saliva sample;   Other: Collecting sputum;   Other: Collecting stool samples;   Other: Lavage/Irrigation
29 Not yet recruiting More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery
Conditions: Benign Neoplasms, Brain;   Brain Cancer;   Brain Neoplasms, Benign;   Brain Neoplasms, Malignant;   Brain Tumor, Primary;   Brain Tumor, Recurrent;   Brain Tumors;   Intracranial Neoplasms;   Neoplasms, Brain;   Neoplasms, Intracranial;   Primary Brain Neoplasms;   Primary Malignant Brain Neoplasms;   Primary Malignant Brain Tumors;   Gliomas;   Glioblastoma
Intervention: Drug: 5-ALA (Gliolan)
30 Recruiting Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
Conditions: Ewing's Family Tumors;   Renal Tumors;   Hepatoblastoma;   Rhabdomyosarcoma;   Soft Tissue Sarcoma;   Primary Malignant Brain Neoplasms;   Retinoblastoma;   Medulloblastoma;   Supra-tentorial Primative Neuro-Ectodermal Tumor (PNET);   Atypical Teratoid/Rhabdoid Tumor (AT/RT);   CNS Tumors;   Germ Cell Tumors
Interventions: Drug: Ifosfamide;   Drug: Etoposide;   Drug: Mesna;   Biological: G-CSF;   Drug: Busulfan;   Drug: Melphalan;   Drug: Thiotepa;   Biological: Autologous stem cell infusion;   Radiation: Radiation;   Drug: Carboplatin;   Drug: Paclitaxel;   Procedure: Leukapheresis
31 Recruiting Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal Carcinomatosis
Conditions: Malignant Neoplasm of Stomach;   Secondary Malignant Neoplasm of Peritoneum;   Secondary Malignant Neoplasm of Other and Unspecified Sites
Intervention: Procedure: HIPEC
32 Recruiting Cancer Research Repository for Individuals With Cancer Diagnosis and High Risk Individuals.
Conditions: Pancreatic Cancer;   Thyroid Cancer;   Lung Cancer;   Esophageal Cancer;   Thymus Cancer;   Colon Cancer;   Rectal Cancer;   GIST;   Anal Cancer;   Bile Duct Cancer;   Duodenal Cancer;   Gallbladder Cancer;   Gastric Cancer;   Liver Cancer;   Small Intestine Cancer;   Peritoneal Surface Malignancies;   Familial Adenomatous Polyposis;   Lynch Syndrome;   Bladder Cancer;   Kidney Cancer;   Penile Cancer;   Prostate Cancer;   Testicular Cancer;   Ureter Cancer;   Urethral Cancer;   Hypopharyngeal Cancer;   Laryngeal Cancer;   Lip Cancer;   Oral Cavity Cancer;   Nasopharyngeal Cancer;   Oropharyngeal Cancer;   Paranasal Sinus Cancer;   Nasal Cavity Cancer;   Salivary Gland Cancer;   Skin Cancer;   CNS Tumor;   CNS Cancer;   Mesothelioma
Intervention:
33 Recruiting Family and Personal History of Malignancy in Intraductal Papillary Mucinous Neoplasm (IPMN)
Conditions: Pancreatic Cancer;   Neoplasm
Intervention:
34 Recruiting Study of PRoliferation and Apoptosis in Rectal Cancer, Predictive & Prognostic biOmarkers: Histopathology and Imaging
Conditions: Neoplasms;   Colorectal Neoplasms;   Rectal Diseases;   Gastrointestinal Neoplasms
Intervention:
35 Recruiting A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer
Conditions: Carcinoma, Renal Cell;   Kidney Diseases;   Kidney Neoplasms;   Urogenital Neoplasms;   Urologic Diseases;   Urologic Neoplasms;   Neoplasms by Histologic Type;   Neoplasms;   Clear-cell Metastatic Renal Cell Carcinoma;   Melanoma;   Triple Negative Breast Cancer;   Bladder Cancer;   Head and Neck Cancer;   Non-small Cell Lung Cancer
Intervention: Drug: Combination of Varlilumab and Atezolizumab
36 Recruiting Evaluating Strategies to Present Colon Cancer Screening Information
Conditions: Colonic Neoplasms;   Colorectal Neoplasms;   Colonic Diseases;   Gastrointestinal Neoplasms
Interventions: Behavioral: Health communication intervention;   Behavioral: Education information
37 Recruiting TAA-Specific CTLS for Solid Tumors (TACTASOM)
Conditions: Bladder Cancer;   Breast Cancer;   Colorectal Cancer;   Endometrial Cancer;   Gastric Cancer;   Head and Neck Cancer;   HCC;   Lung Cancer;   Melanoma;   Neuroblastoma;   Sarcoma (Osteo-, Synovial, Rhabdomyo-, Etc);   Pancreatic Cancer;   Prostate Cancer;   Renal Cell Carcinoma;   Thyroid Cancer
Intervention: Biological: TAA-Specific CTLs
38 Recruiting Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Conditions: Brain and Central Nervous System Tumors;   Intraocular Melanoma;   Lung Cancer;   Melanoma (Skin);   Metastatic Cancer;   Neuroblastoma;   Ovarian Cancer;   Retinoblastoma;   Sarcoma;   Small Intestine Cancer
Interventions: Genetic: DNA analysis;   Other: immunologic technique;   Other: pharmacological study;   Radiation: iodine I 131 monoclonal antibody 3F8;   Radiation: 131I-3F8
39 Recruiting Study of LOXO-101 in Subjects With NTRK Fusion Positive Solid Tumors
Conditions: Carcinoma, Non-Small-Cell Lung;   Thyroid Neoplasms;   Sarcoma;   Colorectal Neoplasms;   Salivary Gland Neoplasms;   Biliary Tract Neoplasms;   Brain Neoplasm, Primary;   Carcinoma, Ductal, Breast;   Melanoma;   Solid Tumors;   Glioblastoma;   Bile Duct Neoplasms;   Astrocytoma;   Head and Neck Squamous Cell Carcinoma;   Pontine Glioma
Intervention: Drug: LOXO-101
40 Recruiting Clinical Trial: Effectiveness and Efficiency of Physical Exercise in Cancer Patients
Conditions: Non-Small-Cell Lung Carcinoma;   Digestive System Neoplasms;   Breast Neoplasms
Interventions: Other: Supervised Physical activity;   Behavioral: education program on healthy habits

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years